The authors regret that the originally published Figs. 1, 2 and 4 were of suboptimal quality and would like to provide a higher-resolution version to improve clarity.
Fig. 1.

Fig. 2.

Fig. 4.

The improved figures are provided below:
In addition, the authors would like to revise the highlights section as follows:
The authors would like to apologise for any inconvenience caused.
Revised Highlights.
DNA damage promotes the release of dsDNA from nuclear, mitochondrial, and micronuclear sources, activating the cGAS-STING pathway.
sensing, potentially requiring PTMs and nuclear export.
Intracellular trafficking may control cGAS-STING signaling to balance immune activation and tolerance.
STING agonists are proposed to enhance tumor immunity, but challenges include delivery, toxicity, and context-dependent immune suppression.
